The threat of new tariffs on drugmakers has set off a debate within the biotech industry over whether to cut voluntary ...

The Biotechnology Innovation Organization is the largest advocacy association in the world that represents the biotechnology industry.Anna Edney, [https://www ...

Biotechnology sits at a fascinating crossroads. As scientific advances uncover the shared mechanisms of oncology and immunology, the traditional boundaries in how we perceive and treat these diseases ...

It has been a decent year for the biotech industry so far, buoyed by new drug approvals and positive regulatory/pipeline updates. The third-quarter earnings season has just kicked off, with most major ...

Co-founder of more than 40 biotechnology companies, including 16 IPOs and 19 successful acquisitions Scientific and medical titan focused on driving innovation for human healthWill assist with listeri ...

Companies have long lamented Europe's fragmented capital markets, single-market adoption on pricing and clinical trials, and ...

The Nasdaq Biotechnology™ Index (NBI®) has been the leading benchmark for the biotech industry since its launch in 1993, reflecting Nasdaq’s historical dominance in attracting biotech IPOs with an ...

T he biotech and pharmaceutical sectors stand at the brink of innovation and strategic transformation. Market momentum continues to build, with the global biotechnology market valued at around $2 ...

The biotech industry has been a robust roller-coaster over the last half decade. The State Street SPDR S&P Biotech ETF (NYSE: ...

This column is from Trendlines, my business newsletter that covers the forces shaping the economy in Boston and beyond. If you’d like to receive it via email on Mondays and Thursdays, sign up here.